User Fees Could Chafe Cosmetics In OTC Monograph Reform Proposal
This article was originally published in The Rose Sheet
Executive Summary
Products marketed for cosmetic use but formulated with drugs are regulated as topical drugs and would be subject to potential OTC user fees, although the products have little similarity with oral or nasal delivery nonprescription drugs also available under FDA's monograph system, consultant David Steinberg says.
You may also be interested in...
Second Wind For OTC Monograph User Fee Legislation In House Hearing
House Health Subcommittee's “Modernizing FDA’s Regulation of Over-the-Counter Drugs” hearing Sept. 13 will "examine draft legislation to establish" a user fee program to support FDA's work on evaluating proposals for additions or changes to its nonprescription drug monographs.
Waiting For Congress: Reforming, Paying For FDA OTC Monograph Program
FDA officials emphasize that without legislation from Congress, the OTC monograph program is not changing, and without a user fee program, the agency couldn’t implement changes.
FDA Seeks $17.7m In User Fees For Mandatory Cosmetic Registration
Again in its budget justification, FDA signals that a Mandatory Cosmetic Registration Program does not come cheap. Legislation would be needed to implement the program, as well as the industry user fees required to support it, but only one cosmetics safety bill currently in play includes a user-fee mechanism to fund proposed facility and product registration with the agency.